Leavell Investment Management, Inc.
Source: SEC Form 13F · as of Mar 2026Leavell Investment Management, Inc. holds 23 biotech & pharma companies tracked by BioSniper, totaling $72.2M in value as of Mar 2026 (SEC Form 13F).
Companies held
23
Total value held
$72.2M
| Company | Shares | Value |
|---|---|---|
| ABBVAbbVie Inc. | 75,024 | $16.3M |
| JNJJOHNSON & JOHNSON | 40,667 | $9.9M |
| LLYELI LILLY & Co | 7,840 | $7.2M |
| AMGNAMGEN INC | 18,004 | $6.3M |
| MRKMerck & Co., Inc. | 41,201 | $5.0M |
| ABTABBOTT LABORATORIES | 33,045 | $3.4M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 11,774 | $3.2M |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 6,660 | $3.0M |
| GEHCGE HealthCare Technologies Inc. | 36,531 | $2.6M |
| BMYBRISTOL MYERS SQUIBB CO | 37,748 | $2.3M |
| CAHCardinal Health Inc. | 10,027 | $2.1M |
| TECHBIO-TECHNE Corp | 39,628 | $2.1M |
| PMPhilip Morris International Inc | 9,719 | $1.6M |
| AZNASTRAZENECA PLC | 6,667 | $1.3M |
| CRSPCRISPR Therapeutics AG | 24,566 | $1.2M |
| PFEPFIZER INC | 37,659 | $1.1M |
| ELVElevance Health Inc. | 2,914 | $853K |
| DGXQuest Diagnostics Incorporated | 3,736 | $732K |
| CRLCHARLES RIVER LABORATORIES INTERNATIONAL, INC. | 3,026 | $522K |
| MCKMcKesson Corporation | 581 | $504K |
| GILDGILEAD SCIENCES, INC. | 2,728 | $380K |
| UTHRUNITED THERAPEUTICS Corp | 628 | $372K |
| IBRXImmunityBio, Inc. | 27,512 | $211K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.